Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Kevin Neal

Anesthesiology Flagstaff, AZ Medical Doctor

NPI 1023402963 CMS profile 7216565

1200 N Beaver St, Flagstaff, AZ 86001

Open in the dashboard

General payments

$3,199

92 records reported · program years 2019–2024

Research payments

$11

Paid to them · 1 record reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Kevin Neal of Flagstaff, AZ is reported in the CMS Open Payments database as having received $3,199 across 92 general payments and $11 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Anesthesiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $26 1
2023 General $32 1
2022 General $419 3
2021 General $378 22
2021 Research $11 1
2020 General $1,572 37
2019 General $772 28

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kevin Neal
  • Anesthesiology median
  • Middle half of Anesthesiology
  • National median

In program year 2025, general payments to Kevin Neal were reported at $0. Among 18,548 Anesthesiology profiles paid that year, the median was $58 and the middle half received between $26 and $153.

Show as a table
Year Kevin Neal Anesthesiology median Middle half National median
2019 $772 $72 $23–$151 $163
2020 $1,572 $36 $17–$120 $114
2021 $378 $49 $21–$135 $132
2022 $419 $52 $22–$144 $149
2023 $32 $53 $23–$143 $160
2024 $26 $55 $25–$150 $164
2025 $0 $58 $26–$153 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Boston Scientific Corporation $1,534 42 payments
  2. Nevro Corp. $442 11 payments
  3. Medtronic, Inc. $248 4 payments
  4. Medtronic USA, Inc. $245 6 payments
  5. Biodelivery Sciences International, Inc. $140 15 payments
  6. SPR Therapeutics, Inc $128 2 payments
  7. MML US, Inc. $122 1 payment
  8. Forte Bio-Pharma LLC $112 1 payment
  9. Saluda Medical Americas, Inc. $61 2 payments
  10. Vertiflex, Inc. $34 1 payment
  11. Other $134 7 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Food and Beverage $3,199 92 payments
Products named General payments · program years 2019–2024
  1. GENERAL - PAIN MANAGEMENT $780 12 payments
  2. Senza Spinal Cord Stimulation System $422 10 payments
  3. GENERAL PAIN MANAGEMENT $382 12 payments
  4. SPECTRA WAVEWRITER $289 13 payments
  5. INTELLIS ADAPTIVESTIM $183 1 payment
  6. INTELLIS $177 3 payments
  7. BELBUCA $140 15 payments
  8. SPRINT PNS System $128 2 payments
  9. ReActiv8 $122 1 payment
  10. NALOCET $112 1 payment
  11. Other $577 23 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2024
  1. Saluda Medical Americas, Inc. $11 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

45

Median for Anesthesiology: 322

Drug cost

$5,908

Median for Anesthesiology: $8,738

Branded share of claims

40%

Median for Anesthesiology: 25.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 18 $5,349
Methocarbamol Generic 13 $361
Gabapentin Generic 14 $198

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,517 Part D prescribers listed as Anesthesiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 75 billing codes

Paid by Medicare

$19,048

Medicare's payments for the services billed

Medicare patients

167

Average age 70

Services billed

207

84 women, 83 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 67%
Diabetes 37%
Depression 36%
Ischemic heart disease 29%
Chronic kidney disease 27%
Cancer 26%
Heart failure 25%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

93 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record